{'52WeekChange': -0.00683856,
 'SandP52WeekChange': None,
 'address1': '4747 Executive Drive',
 'address2': 'Suite 510',
 'algorithm': None,
 'annualHoldingsTurnover': None,
 'annualReportExpenseRatio': None,
 'ask': 36.15,
 'askSize': 800,
 'averageDailyVolume10Day': 54887,
 'averageVolume': 79044,
 'averageVolume10days': 54887,
 'beta': 1.139703,
 'beta3Year': None,
 'bid': 14.14,
 'bidSize': 1300,
 'bookValue': 4.216,
 'category': None,
 'circulatingSupply': None,
 'city': 'San Diego',
 'companyOfficers': [],
 'country': 'United States',
 'currency': 'USD',
 'dateShortInterest': 1593475200,
 'dayHigh': 37.75,
 'dayLow': 35.83,
 'dividendRate': None,
 'dividendYield': None,
 'earningsQuarterlyGrowth': None,
 'enterpriseToEbitda': -8.714,
 'enterpriseToRevenue': None,
 'enterpriseValue': 1012316032,
 'exDividendDate': None,
 'exchange': 'NMS',
 'exchangeTimezoneName': 'America/New_York',
 'exchangeTimezoneShortName': 'EDT',
 'expireDate': None,
 'fiftyDayAverage': 39.880287,
 'fiftyTwoWeekHigh': 46.5,
 'fiftyTwoWeekLow': 18.07,
 'fiveYearAverageReturn': None,
 'fiveYearAvgDividendYield': None,
 'floatShares': 12539670,
 'forwardEps': -3.24,
 'forwardPE': -11.1882715,
 'fromCurrency': None,
 'fullTimeEmployees': 134,
 'fundFamily': None,
 'fundInceptionDate': None,
 'gmtOffSetMilliseconds': '-14400000',
 'headSymbol': None,
 'heldPercentInsiders': 0.07406,
 'heldPercentInstitutions': 0.97319,
 'industry': 'Biotechnology',
 'isEsgPopulated': False,
 'lastCapGain': None,
 'lastDividendValue': None,
 'lastFiscalYearEnd': 1577750400,
 'lastMarket': None,
 'lastSplitDate': None,
 'lastSplitFactor': None,
 'legalType': None,
 'logo_url': 'https://logo.clearbit.com/odonate.com',
 'longBusinessSummary': 'Odonate Therapeutics, Inc., a pharmaceutical company, '
                        'develops therapeutics for the treatment of cancer. It '
                        'is developing tesetaxel, an orally administered '
                        'chemotherapy agent, which is in Phase III clinical '
                        'study for patients with locally advanced or '
                        'metastatic breast cancer; and CONTESSA 2 and CONTESSA '
                        'TRIO, which is in Phase II clinical study for central '
                        'nervous system metastases and various cancer '
                        'treatments. The company was founded in 2013 and is '
                        'based in San Diego, California.',
 'longName': 'Odonate Therapeutics, Inc.',
 'market': 'us_market',
 'marketCap': 1163980288,
 'maxAge': 1,
 'maxSupply': None,
 'messageBoardId': 'finmb_541399578',
 'morningStarOverallRating': None,
 'morningStarRiskRating': None,
 'mostRecentQuarter': 1585612800,
 'navPrice': None,
 'netIncomeToCommon': -113343000,
 'nextFiscalYearEnd': 1640908800,
 'open': 37.75,
 'openInterest': None,
 'payoutRatio': 0,
 'pegRatio': None,
 'phone': '858 731 8180',
 'previousClose': 37.76,
 'priceHint': 2,
 'priceToBook': 8.598197,
 'priceToSalesTrailing12Months': None,
 'profitMargins': 0,
 'quoteType': 'EQUITY',
 'regularMarketDayHigh': 37.75,
 'regularMarketDayLow': 35.83,
 'regularMarketOpen': 37.75,
 'regularMarketPreviousClose': 37.76,
 'regularMarketPrice': 37.75,
 'regularMarketVolume': 52628,
 'revenueQuarterlyGrowth': None,
 'sector': 'Healthcare',
 'sharesOutstanding': 32109800,
 'sharesPercentSharesOut': 0.0238,
 'sharesShort': 764257,
 'sharesShortPreviousMonthDate': 1590710400,
 'sharesShortPriorMonth': 625543,
 'shortName': 'Odonate Therapeutics, Inc.',
 'shortPercentOfFloat': 0.0572,
 'shortRatio': 7.24,
 'startDate': None,
 'state': 'CA',
 'strikePrice': None,
 'symbol': 'ODT',
 'threeYearAverageReturn': None,
 'totalAssets': None,
 'tradeable': False,
 'trailingAnnualDividendRate': None,
 'trailingAnnualDividendYield': None,
 'trailingEps': -3.894,
 'twoHundredDayAverage': 31.796043,
 'underlyingExchangeSymbol': None,
 'underlyingSymbol': None,
 'uuid': '23adbb49-bffc-35a4-8a19-a19eb1fc8328',
 'volume': 52628,
 'volume24Hr': None,
 'volumeAllCurrencies': None,
 'website': 'http://www.odonate.com',
 'yield': None,
 'ytdReturn': None,
 'zip': '92121'}